US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

227.75

-3.2000-1.39%

Post-market: 228.901.15+0.50%19:43 EDT

Volume:433.27K

Turnover:99.88M

Market Cap:540.79M

PE:- -

High:237.30

Open:224.64

Low:220.50

Close:230.95

52wk High:341.93

52wk Low:100.18

Shares:2.37M

Float Shares:2.37M

Volume Ratio:0.87

T/O Rate:18.25%

Dividend:0.90

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

ETF & Stock Investment-0.31%

Fractional Shares-0.31%

Capital Flow

Inflow:

Outflow:

News

Imricor Medical Systems Says FDA Completes Review of PMA Module Three

MT Newswires Live

Imricor Clears Major FDA Hurdle on MR-Guided Ablation Platform

FDA feedback de-risks Noxopharm’s SOF-SKN Phase II trial plans

Healthcare Services expands via NEXDINE acquisition agreement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/LABU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":227.75,"timestamp":1791403200000,"preClose":230.95,"halted":0,"volume":433267,"hourTrading":{"tag":"盘后","latestPrice":228.9,"preClose":227.75,"latestTime":"19:43 EDT","volume":1266,"amount":289334.77968000004,"timestamp":1791416602267,"change":1.15,"changeRate":0.005049,"amplitude":0.007157},"delay":0,"changeRate":-0.013855812946525173,"floatShares":2374486,"shares":2374486,"eps":0,"marketStatus":"Post-Mkt","change":-3.2,"latestTime":"10-07 19:45:20 EDT","open":224.64,"high":237.3,"low":220.5,"amount":99879720.04565,"amplitude":0.072743,"askPrice":229.2,"askSize":200,"bidPrice":228,"bidSize":5,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791417600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":230.95,"sharesOutstanding":3074486,"nav":256.391,"aum":621616713.42,"dividendRate":0.003955,"bidAskSpread":0.003379,"preHourTrading":{"tag":"盘前","latestPrice":224.0088,"preClose":230.95,"latestTime":"09:29 EDT","volume":6714,"amount":1524137.95602,"timestamp":1791379753481,"change":-6.9412,"changeRate":-0.030055,"amplitude":0.031695},"postHourTrading":{"tag":"盘后","latestPrice":228.9,"preClose":227.75,"latestTime":"19:43 EDT","volume":1266,"amount":289334.77968000004,"timestamp":1791416602267,"change":1.15,"changeRate":0.005049,"amplitude":0.007157},"volumeRatio":0.866914,"impliedVol":0.9774,"impliedVolPercentile":0.745},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2374486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.866914,"shares":2374486,"dividePrice":0.9008,"high":237.3,"amplitude":0.072743,"preClose":230.95,"low":220.5,"week52Low":100.18,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":227.75,"committee":-0.95122,"eps":0,"divideRate":0.003955,"volume":433267,"delay":0,"ttmEps":0,"open":224.64,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":265.79,"twentyDayClose":279.02,"sixtyDayClose":274.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673046364","title":"Imricor Medical Systems Says FDA Completes Review of PMA Module Three","url":"https://stock-news.laohu8.com/highlight/detail?id=2673046364","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673046364?lang=en_us&edition=fundamental","pubTime":"2026-10-08 07:41","pubTimestamp":1791416498,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said the US Food and Drug Administration has completed its review of module three of the company's premarket approval  submission, which covers non-clinical bench testing for its Vision-MR ablation catheter 2.0, RF-5000 system and irrigation tubing set, according to a Thursday Australian bourse filing.No deficiencies were identified in the catheter or tubing set, while one deficiency was found in the RF-5000 system's third-party software operating system, which the company has already upgraded to a long-term supported version, per the filing.The company is preparing its response to the FDA, with module three expected to close upon acceptance and module four targeted for submission in November, thereby completing all PMA submissions, the filing added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7007","BK7503","LABU","PMA","BK4585","IMR.AU","BK4588","BK4129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673045533","title":"Imricor Clears Major FDA Hurdle on MR-Guided Ablation Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2673045533","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673045533?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:29","pubTimestamp":1791412149,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:IMR) ). Imricor Medical Systems, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/imricor-clears-major-fda-hurdle-on-mr-guided-ablation-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/imricor-clears-major-fda-hurdle-on-mr-guided-ablation-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673404398","title":"FDA feedback de-risks Noxopharm’s SOF-SKN Phase II trial plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2673404398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673404398?lang=en_us&edition=fundamental","pubTime":"2026-10-08 05:30","pubTimestamp":1791408627,"startTime":"0","endTime":"0","summary":"Noxopharm Ltd. ( ($AU:NOX) ) just unveiled an update. Noxopharm has received supportive feedback from the U.S. Food and Drug Administration on its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fda-feedback-de-risks-noxopharms-sof-skn-phase-ii-trial-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fda-feedback-de-risks-noxopharms-sof-skn-phase-ii-trial-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOF","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673043623","title":"Healthcare Services expands via NEXDINE acquisition agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2673043623","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673043623?lang=en_us&edition=fundamental","pubTime":"2026-10-08 05:29","pubTimestamp":1791408544,"startTime":"0","endTime":"0","summary":"An update from Healthcare Services ( ($HCSG) ) is now available. On October 6, 2026, Healthcare Services Group, Inc. entered into an agreement to a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthcare-services-expands-via-nexdine-acquisition-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthcare-services-expands-via-nexdine-acquisition-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0128526141.USD","HCSG","BK4585","XLV","LU0029874061.USD","BK4581","BK4137","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":105,"pageCount":1,"totalSize":420,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LABU\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF & Stock Investment","id":"package_us_concept_etf&gpdt","bkCode":"BK4585","changeRate":-0.003102},{"market":"US","name":"Fractional Shares","id":"package_us_concept_sg","bkCode":"BK4588","changeRate":-0.003084}]}}